XMT-2056, a HER2-Directed STING Agonist Antibody–Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune CellsRaghida A. Bukhalid, Timothy B. Lowinger|Clinical Cancer Research|2025Cited by 32